Senores Pharmaceuticals Announcements
Senores Pharmaceuticals Limited has informed the Exchange regarding Outcome of Board Meeting held on January 07, 2026
07 Jan, 2026 | 06:11pm • Source: BSE
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Renosen Pharmaceuticals Pvt Ltd
01 Jan, 2026 | 03:53pm • Source: BSE
Senores Pharmaceuticals Limited has informed the Exchange regarding revised intimation in respect of earlier intimation dated December 29, 2025 under Regulation 30 of Securities and...
30 Dec, 2025 | 06:25pm • Source: BSE
Senores Pharmaceuticals Limited has informed the Exchange regarding intimation under Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations,...
29 Dec, 2025 | 06:46pm • Source: BSE
Senores Pharmaceuticals Limited has informed the Exchange regarding Business Update Call held on December 16, 2025
22 Dec, 2025 | 05:26pm • Source: BSE
Senores Pharmaceuticals Limited has informed the Exchange regarding granting of Inter Corporate Loan
20 Dec, 2025 | 02:49pm • Source: BSE
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Renosen Pharmaceuticals Pvt Ltd
18 Dec, 2025 | 12:29pm • Source: BSE
Senores Pharmaceuticals Limited has informed the Exchange regarding Business update call
15 Dec, 2025 | 07:57pm • Source: BSE
Senores Pharmaceuticals Limited has informed the Exchange regarding Business update presentation
15 Dec, 2025 | 07:54pm • Source: BSE
Senores Pharmaceuticals Limited has informed the Exchange regarding Acquisition
15 Dec, 2025 | 07:47pm • Source: BSE
Senores Pharmaceuticals Limited has informed the Exchange regarding Analyst/Institutional Investor meet scheduled to be held on December 11, 2025
05 Dec, 2025 | 06:08pm • Source: BSE
Senores Pharmaceuticals Limited has informed the Exchange regarding a press release dated December 05, 2025, titled "Senores Pharmaceuticals receives Philippine FDA approval for 10 products
05 Dec, 2025 | 03:22pm • Source: NSE
Senores Pharmaceuticals Limited has informed the Exchange regarding press release dated December 05, 2025 titled "Senores Pharmaceuticals receives Philippine FDA approval for 10 products."
05 Dec, 2025 | 03:16pm • Source: BSE
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on December 04, 2025 for...
05 Dec, 2025 | 10:34am • Source: BSE
Senores Pharmaceuticals Limited has informed the Exchange regarding copy of Newspaper publication for Unaudited Standalone and Consolidated financial results for quarter and half year ended...
07 Nov, 2025 | 12:50pm • Source: NSE
Senores Pharmaceuticals Limited has informed the Exchange regarding copy of Newspaper publication for Unaudited Standalone and Consolidated financial results for quarter and half year ended...
07 Nov, 2025 | 11:05am • Source: BSE
Senores Pharmaceuticals Limited has informed the Exchange regarding link of Audio recording of Earnings Conference Call for quarter and half year ended September 30,...
06 Nov, 2025 | 07:55pm • Source: BSE
Senores Pharmaceuticals Limited has informed the Exchange regarding Monitoring Agency Report for the quarter ended September 30, 2025
06 Nov, 2025 | 05:07pm • Source: BSE
Senores Pharmaceuticals Limited has informed the Exchange regarding changes in the Senior Management Personnel ("SMP") of the Company
06 Nov, 2025 | 03:04pm • Source: BSE
Senores Pharmaceuticals Limited has informed the Exchange regarding Investor Presentation for Q2 & H1FY26
06 Nov, 2025 | 02:18pm • Source: BSE